J Torres, R Silva, G Farias, JM Sousa Lobo… - Pharmaceutics, 2024 - mdpi.com
Migraine has a high prevalence worldwide and is one of the main disabling neurological diseases in individuals under the age of 50. In general, treatment includes the use of oral …
N Svane, F Bällgren, A Ginosyan, M Kristensen… - The Journal of …, 2024 - Springer
Background Triptans are potent 5-HT1B/1D/1F receptor agonists used in migraine therapy, thought to act through peripheral mechanisms. It remains unclear whether triptans cross the …
WH Liu, HM Hu, C Li, Q Shi, CH Liu, AX Liu… - The Journal of …, 2024 - Springer
Abstract Background Triptans selectively agoniste 5-Hydroxytryptamine (5-HT) receptors and are widely used in the treatment of migraine. Nevertheless, there is a dearth of …
M Waliszewska-Prosół, B Raffaelli… - Expert Review of …, 2024 - Taylor & Francis
Introduction The discovery of the role of the calcitonin gene-related peptide (CGPR) in migraine pathogenesis ushered in a new era in headache medicine. This evidence led to …
After 44 days of strike action over the past two years, resident doctors (as junior doctors will now be known) have voted to accept the government's latest pay offer, with two thirds of …
HC Diener, U Reuter - DGNeurologie, 2024 - Springer
Viele Patienten können erfolgreich ihre leichten oder mittelschweren Migräneattacken mit Analgetika oder nichtsteroidalen Antirheumatika behandeln. Die meisten dieser …
I triptani sono più efficaci rispetto ai trattamenti convenzionali ea quelli innovativi nella gestione degli episodi di emic Page 1 POEMs Recenti Prog Med 2025; 116: 53-54 53 …
1. Peptide correlato al gene della calcitonina (CGRP) pag. 65 1.1. Struttura molecolare del peptide ³-CGRP e meccanismo d9azione pag. 67 1.2. Recettore del CGRP e legame CGRP …
A rare coin-shaped headache long viewed as a primary headache disorder frequently has underlying causes, according to new research, and clinicians should refer people who …